Viewing Study NCT01038635

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:35 PM
Ignite Modification Date: 2025-12-31 @ 3:14 PM
Study NCT ID: NCT01038635
Status: COMPLETED
Last Update Posted: 2017-02-10
First Post: 2009-12-23
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: 5-Azacytidine With Lenalidomide in Patients With High Risk Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None 5-Azacytidine View
None 5-Aza View
None Lenalidomide View
None Revlimid View
None CC-5103 View
None Myelodysplastic Syndrome View
None MDS View
None Acute Myelogenous Leukemia View
None AML View